![Lindsey Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lindsey Rolfe
Hoofd Techniek/Wetenschap/O&O bij
3B Pharmaceuticals GmbH
Vermogen: - $ op 31-08-2026
Profiel
Lindsey Rolfe is currently an Independent Director at CERo Therapeutics Holdings, Inc. since 2024 and Chief Medical Officer at 3B Pharmaceuticals GmbH since 2023.
Former roles include Independent Director at Atreca, Inc. from 2019 to 2024, Member of The Royal College of Physicians, and Chief Medical Officer & Executive VP-Clinical at Clovis Oncology, Inc. from 2015 to 2023.
Education includes a doctorate from The University of Edinburgh.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 28-04-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Lindsey Rolfe
| Bedrijven | Functie | Begin |
|---|---|---|
3B Pharmaceuticals GmbH
 3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Hoofd Techniek/Wetenschap/O&O | 01-08-2023 |
Eerdere bekende functies van Lindsey Rolfe
| Bedrijven | Functie | Einde |
|---|---|---|
| ATRECA, INC. | Directeur/Bestuurslid | 01-05-2024 |
| CLOVIS ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Lindsey Rolfe
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
3B Pharmaceuticals GmbH
3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Commercial Services |
